The SIC Annual Meeting is the focal point of the Italian cancer research community, where preclinical and clinical scientists gather together to share the latest advances in cancer research and cure. In the last few years, we have witnessed, as never before, the rapid translation of preclinical research into clinical application.
The program of the 62nd SIC Annual Meeting, entitled “The exciting path from preclinical research to clinical application” will focus on the challenges posed by the rapid development of the precision medicine approaches, including the need for a better understanding of tumor heterogeneity and drug resistance mechanisms, and the ongoing efforts necessary for a better patients stratification for radio-, chemo-, targeted- and immune- therapies, to increase the number of patients with durable clinical responses.
